DK200189A - Hiv-env-kodet peptid, der kan udvaelge hiv-inhiberende antistoffer hos pattedyr - Google Patents

Hiv-env-kodet peptid, der kan udvaelge hiv-inhiberende antistoffer hos pattedyr Download PDF

Info

Publication number
DK200189A
DK200189A DK200189A DK200189A DK200189A DK 200189 A DK200189 A DK 200189A DK 200189 A DK200189 A DK 200189A DK 200189 A DK200189 A DK 200189A DK 200189 A DK200189 A DK 200189A
Authority
DK
Denmark
Prior art keywords
peptid
mammals
encoded
hiv env
animal antibody
Prior art date
Application number
DK200189A
Other languages
Danish (da)
English (en)
Other versions
DK200189D0 (da
Inventor
William Robert Kenealy
Stephen Robert Petteway
Paul John Durda
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/324,027 external-priority patent/US5562905A/en
Application filed by Du Pont filed Critical Du Pont
Publication of DK200189D0 publication Critical patent/DK200189D0/da
Publication of DK200189A publication Critical patent/DK200189A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK200189A 1988-04-26 1989-04-25 Hiv-env-kodet peptid, der kan udvaelge hiv-inhiberende antistoffer hos pattedyr DK200189A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18633388A 1988-04-26 1988-04-26
US07/324,027 US5562905A (en) 1988-04-26 1989-03-20 Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals

Publications (2)

Publication Number Publication Date
DK200189D0 DK200189D0 (da) 1989-04-25
DK200189A true DK200189A (da) 1989-10-27

Family

ID=26881983

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200189A DK200189A (da) 1988-04-26 1989-04-25 Hiv-env-kodet peptid, der kan udvaelge hiv-inhiberende antistoffer hos pattedyr

Country Status (10)

Country Link
EP (1) EP0339504A3 (fi)
JP (1) JPH02160800A (fi)
AU (1) AU632475B2 (fi)
DK (1) DK200189A (fi)
FI (1) FI891957A (fi)
HU (1) HUT51296A (fi)
IL (1) IL90058A0 (fi)
NO (1) NO891711L (fi)
NZ (1) NZ228869A (fi)
PT (1) PT90376B (fi)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE148918T1 (de) * 1989-04-25 1997-02-15 Tanox Biosystems Inc Für die co4-bindende domäne von hiv spezifische antikörper
PT94276A (pt) * 1989-06-05 1991-02-08 Anticorpo monoclonal capaz de neutralizar o prototipo mn de hiv
SE9000333D0 (sv) * 1990-01-31 1990-01-31 Britta Wahren Monoklonal antikropp
US7041293B1 (en) 1990-04-03 2006-05-09 Genentech, Inc. HIV env antibodies
JP3494300B2 (ja) * 1990-04-03 2004-02-09 ジェネンテック・インコーポレーテッド Ｈｉｖに対する予防接種のための方法および組成物
WO1992000098A1 (en) * 1990-06-29 1992-01-09 Daniel Zagury Methods of inducing immune response to aids virus
JP2989862B2 (ja) * 1990-07-02 1999-12-13 財団法人化学及血清療法研究所 モノクローナル抗体
US5712373A (en) * 1990-07-02 1998-01-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute HIV monoclonal antibody specific for the HTLV-IIImn gp120 envelope glycoprotein
CA2047073A1 (en) * 1990-07-19 1992-01-20 William J. Leanza Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
IL99077A0 (en) * 1990-08-13 1992-07-15 Merck & Co Inc New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them
US5627035A (en) * 1990-08-22 1997-05-06 Syntello Vaccine Development Ab Peptides that block human immunodeficiency virus and methods of use thereof
US5346989A (en) * 1990-08-22 1994-09-13 Syntello Vaccine Development Kb Peptides for use in induction of T cell activation against HIV-1
WO1992021377A1 (en) * 1991-06-03 1992-12-10 Syntello Inc. Peptides for use in induction of t cell activation against hiv-1
US5665569A (en) * 1991-08-22 1997-09-09 Nissin Shokuhin Kabushiki Kaisha HIV immunotherapeutics
ATE173024T1 (de) * 1991-08-22 1998-11-15 Nissin Food Products Ltd In der therapie von einer hiv-1-infektion verwendbare monoklonale antikörper
PT671947E (pt) * 1991-12-02 2000-07-31 Univ Texas Composicoes para produzir respostas de linfocitos t citotoxicas contra virus
IL103928A0 (en) * 1991-12-11 1993-04-04 American Home Prod Expression of specific immunogens using viral antigens
JPH0748276A (ja) * 1992-03-26 1995-02-21 Inmeru:Kk Ｈｉｖ感染症予防ワクチンおよびその製造法
WO1993019775A1 (en) * 1992-03-31 1993-10-14 Medimmune, Inc. Administration of liposomes containing peptides or proteins including ctl eptitopes of hiv proteins
AU5359094A (en) * 1992-10-13 1994-05-09 Children's Hospital Oral tolerance and immune suppression in the treatment of aids
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
DK0690132T3 (da) * 1993-03-11 2004-04-13 Chemo Sero Therapeut Res Inst Monoklonalt anti-HIV-antistof
US6180134B1 (en) 1993-03-23 2001-01-30 Sequus Pharmaceuticals, Inc. Enhanced ciruclation effector composition and method
AU700371B2 (en) 1993-06-07 1999-01-07 Genentech Inc. Hiv envelope polypeptides
JPH09506428A (ja) * 1993-10-15 1997-06-24 エム． ラコウィック−ズルチェンスカー，エバ 乳癌および婦人科の癌の検出および治療
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
ZA975889B (en) * 1996-07-08 1998-02-23 Genentech Inc HIV envelope polypeptides and vaccine.
FR2874612A1 (fr) * 2004-08-27 2006-03-03 Commissariat Energie Atomique Epitotes t cd4+ du vih restreints a hla-dp4 et leurs applications
EP2778681A1 (en) * 2013-03-15 2014-09-17 Biomay Ag Method for diagnosing a viral infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2571968B1 (fr) * 1984-10-18 1989-03-17 Pasteur Institut Virus purifie des lymphadenopathies et du syndrome d'immuno-depression acquise et antigenes d'enveloppe de ce virus, procede d'obtention de ce virus et de ces antigenes d'enveloppe de ce virus, applications de ce virus ou de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic des susdites affections.
EP0201540B2 (en) * 1984-10-18 2001-10-31 Institut Pasteur Envelope antigens of lymphadenopathy associated virus and their applications
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
ATE108022T1 (de) * 1985-10-24 1994-07-15 Southwest Found Biomed Res Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc.
AU617088B2 (en) * 1986-06-12 1991-11-21 Biogen, Inc. Peptides involved in the pathogenesis of hiv infection
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
JP2520464B2 (ja) * 1987-05-29 1996-07-31 タノツクス・バイオシステムズ・インコーポレーテツド Ｈｉｖ―１を中和するモノクロ―ナル抗体
WO1989007112A1 (en) * 1988-01-26 1989-08-10 The United States Of America, As Represented By Th A synthetic antigen evoking anti-hiv response

Also Published As

Publication number Publication date
DK200189D0 (da) 1989-04-25
FI891957A (fi) 1989-10-27
NO891711L (no) 1989-10-27
IL90058A0 (en) 1989-12-15
EP0339504A3 (en) 1990-09-12
NO891711D0 (no) 1989-04-25
EP0339504A2 (en) 1989-11-02
PT90376A (pt) 1989-11-10
HUT51296A (en) 1990-04-28
AU632475B2 (en) 1993-01-07
JPH02160800A (ja) 1990-06-20
NZ228869A (en) 1992-02-25
FI891957A0 (fi) 1989-04-25
PT90376B (pt) 1995-01-31
AU3332089A (en) 1989-11-02

Similar Documents

Publication Publication Date Title
DK200189D0 (da) Hiv-env-kodet peptid, der kan udvaelge hiv-inhiberende antistoffer hos pattedyr
DE69021002D1 (de) Schimärische Hepadnavirus-Kernantigenproteine.
DK666389D0 (da) Monoklonalt antistof
DE68914244D1 (de) Monoklonaler Antikörper.
DE69018801D1 (de) Chimärischer anti-cae-antikörper.
NO924279D0 (no) Lyofilisert, monoklonalt antistoffpreparat
DE3879452D1 (de) Chimaere antikoerper.
NO881151D0 (no) Syntetisk hiv-1-antigen.
DE3888921D1 (de) Polypeptide.
DE3885355D1 (de) Monoklonale Antikörper.
DK63187D0 (da) Krydsbeskyttende monoklonale antistofpraeparater
NO890774D0 (no) Ekspresjon av hiv-bindende proteiner.
DE3880699D1 (de) Thyristor vom nulldurchgangstyp.
DE3879968D1 (de) Malaria-impfstoff aus copolymerem protein.
NO177311C (no) Anti-fucosylceramid monoklonalt antistoff
FI893545A0 (fi) Maenskans protein c-mutanter och foerfarande foer deras framstaellning.
DK717888D0 (da) Monoklonale antistoffer
DE3780256D1 (de) Anti-pci-monoklonaler antikoerper.
DK69690D0 (da) Humane anti-rh(d) monoklonale antistoffer
FI904357A0 (fi) Foerfarande foer aktivering av protein c.
DK69590D0 (da) Humane anti-rh(d) monoklonale antistoffer
NO873488D0 (no) Monoklonale antistoffer.
FI893450A (fi) Modifierade proteiner.
NO890116D0 (no) Monoklonale antistoffer.
DE3687542D1 (de) Monoklonaler antikoerper gegen humanes protein c.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment